HYDROFARM HOLDINGS GROUP, INC.

ITEM 1A. RISK FACTORS

For a discussion of risk factors, please read Item 1A, "Risk Factors" in our 2025 Annual Report. Such risk factors continue to be relevant to an understanding of our business, financial condition and operating results. As of the date of this Quarterly Report on Form 10-Q, there have been the following material changes with respect to such risk factors:

We are currently not in compliance with the continued listing standards of Nasdaq, and if we are unable to regain compliance, our common stock willmay be delisted from the exchange.

Our common stock is currently listed for trading on the Nasdaq under the symbol HYFM. The continued listing of our common stock on Nasdaq is subject to our compliance with a number of listing standards, including Nasdaq Listing Rule 5550(b)(1) to maintain a minimum of $2.5 million in stockholders equity (the Minimum Stockholders Equity Requirement) or the alternative requirements of Nasdaq Listing Rule 5550(b)(2)-(3) of having a market value of listed securities of at least $35 million or net income from continuing operations of $500,000 in the most recently completed fiscal year or two of the last three most recently completed fiscal years (the Alternative Requirement). As of December 31, 2025, we had a stockholders' deficit of approximately $(63) million, the market value of our listed securities was below $35 million as of the date of our 2025 Annual Report, and we realized a net loss in each of the past three fiscal years. Accordingly, we do not meet the requirements of the Minimum Stockholders Equity Requirement or Alternative Requirement.

On April 1, 2026, we received a letter (the Letter) from the Listing Qualifications Department of the Nasdaq indicating that we were not in compliance with the mMinimum sStockholders eEquity rRequirement for continued listing on the Nasdaq Capital Market, under Nasdaq Listing Rule 5550(b)(1), because our stockholders deficit of ($$(63) million as reported in our 2025 Annual Report was below the required minimum of $2.5 million, and because, as of March 31, 2026, we did not meet the aAlternative compliance standardsRequirement relating to the market value of listed securities of $35 million or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last three most recently completed fiscal years.

The LeOn June 16, 2026, we received a letter has no immediate impact from Nasdaq indicating that, based on the listingNasdaqs review of our common stock, which will continue to be listhe Companys plan submitted on May 18, 2026 and related and tradmaterials submitted on the June 8, 2026, Nasdaq underhas granted the symbol HYFM, subjectCompany an extension to ourregain compliance with the other continued listing rMinimum Stockholders Equity Requirements. We have 45 calendar days . On July 2, 2026, we received a determination letter from April 1, 2026, or until May 16, 2026, to submit to Nasdaq notifying us that we did not meet the terms of the extension granted by Nasdaq a plan to regain compliance with Listing Rule 5550(b)(1). If the Minimum Stockholders Equity Requirement (the Nasdaq accepts our plan, Determination Letter). The Nasdaq may grant an extension Determination Letter stated that we may request an appeal of up to 180 calendar days from April 1this determination at a hearing before the Nasdaq Hearing Panel (the Panel) by July 9, 2026, or until September 28. On July 9, 2026, towe timely regain compliance. If quested a hearing before the Panel, which stayed any further action by Nasdaq does not accept our plan, we will have the right to appeal such decision toat least pending completion of the hearing process and the expiration of any extension period that may be granted by the Panel.

On July 6, 2026, we also received a letter from Nasdaq hearings panel. The hearing request would stay any suspension or delindicating that we are not in compliance with the minimum bid price requirement for continued listing on Nasdaq under Listing action pending the issuanRule 5550(a)(2) (the Bid Price Requirement) because we had not maintained a minimum closing bid price of a written panel decision.

We are currently evaluating vario$1 per share for the prior 30 consecutive business days. The Bid Price Requirement provides us courses of action a compliance period of 180 calendar days in which to regain compliance and intends to submit to Nasdaq, within the requisite time period, a plan to . If at any time during the 180-day period, the closing bid price of our common stock is at least $1 for a minimum of ten consecutive business days, Nasdaq will provide written confirmation to us of compliance. In the event that we do not regain compliance with Listing Rule 5550(b)(1)the Bid Price Requirement, we may be eligible for additional time. Ther Company intends tomonitor the can be no assurance that Nlosing bid price of its common stock and is considering its options to regain compliance with the Bid Price Requirement.

40

We asdaq will accept our plan orre considering all options available to us to regain compliance with the Minimum Stockholders Equity Requirement and Bid Price Requirement. However, thatere can be no assurance that we will be able to regain compliance with Listing Rule 5550(b)(1) the Minimum Stockholders Equity Requirement and Bid Price Requirement or maintaiwill otherwise be in compliance with any other applicable Nasdaq requirement Listing Rules, that the Panel will grant the Company an additional extension period to remain the futurelisted on Nasdaq, or that the Panel will be successful.

If we fail to regain compliance with the Nasdaq continued listing standards, after any compliance period, if granted, or we fail to comply with other continued listing requirements, Nasdaq will provide notice that our common stock will be subject to delisting, which could adversely affect our ability to raise additional financing through the public or private sale of equity securities, would significantly affect the ability of investors to trade our securities and would negatively affect the value and liquidity of our common stock. Delisting could also have other negative results, including the potential loss of confidence by employees, the loss of institutional investor interest and fewer business development opportunities. If our common stock is delisted by Nasdaq, the price of our common stock may decline and our common stock may be eligible to trade on the OTC Bulletin Board, another over-the-counter quotation system, or on the pink sheets where an investor may find it more difficult to dispose of their common stock or obtain accurate quotations as to the market value of our common stock. A delisting from Nasdaq and failure to obtain listing on another market or exchange would subject our common stock to so-called penny stock rules that impose additional sales practice and market-making requirements on broker-dealers who sell or make a market in such securities. Further, if we are delisted, we would incur additional costs under requirements of state blue sky laws in connection with any sales of our securities. These requirements could severely limit the market liquidity of our common stock and the ability of our stockholders to sell our common stock in the secondary market.